Inventor · disambiguated record
Steven H. Olson
Also filed as: OLSON STEVEN · OLSON STEVEN H · OLSON STEVEN HOWARD
24 granted patents·18 pending applications·314 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
42 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0497US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0597US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0695US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0795US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0895US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 0995US6730690B211-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemiaMERCK & CO INC·Filed 2003·Granted May 4, 2004·108 cites·42 claims
- 1090US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 1189US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 1288US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1388US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1487US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1586US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1681US7179802B211-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemiaMERCK & CO INC·Filed 2003·Granted Feb 20, 2007·14 cites·14 claims
- 1780US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 1880US6916846B2Coumermycin analogs as chemical dimerizers of chimeric proteinsMERCK & CO INC·Filed 2001·Granted Jul 12, 2005·21 cites·26 claims
- 1980US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2074US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2174US2024199604A1Supramolecular polymer therapeutics and diagnosticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2274US2024197682A1Method for treating neurological diseases using supramolecule polymer therapeuticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2374US2024201205A1Method for detecting neurological diseases using supramolecule polymer therapeuticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2472US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 2571US6630510B1Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infectionsMERCK & CO INC·Filed 2000·Granted Oct 7, 2003·6 cites·31 claims
- 2670US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 2768US9758495B2Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Sep 12, 2017·1 cites·37 claims
- 2867US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2965US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3064US12297171B2EP2 antagonist compoundsRESERVOIR NEUROSCIENCE INC·Filed 2023·Granted May 13, 2025·0 cites·17 claims
- 3164US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3259US2005043538A1Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinoneUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 3356US2025230205A1Treating protein misfolding disordersOLSON STEVEN·Filed 2025·Application pending·0 cites
- 3452US2003073721A1Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinoneUNIV CALIFORNIA A CALIFORNIA C·Filed 2002·Application pending·0 cites
- 3552US2024180882A1Compounds for protection of noise-induced hearing-lossUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3651US2024182459A1Ep2 antagonist compoundsRESERVOIR NEUROSCIENCE INC·Filed 2023·Application pending·0 cites
- 3750US2025188026A1EP2 Antagonist CompoundsRESERVOIR NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 3846US2003207859A1Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infectionsFiled 2003·Application pending·0 cites
- 3946US2016002185A1Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 4044US2003078418A1Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infectionsFiled 2002·Application pending·0 cites
- 4143US11407721B2CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2018·Granted Aug 9, 2022·0 cites·46 claims
- 4239US7329683B211-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemiaMERCK & CO INC·Filed 2003·Granted Feb 12, 2008·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Steven H. Olson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →